Catherine T Doherty's most recent trade in Quest Diagnostics, Inc. was a trade of 5,370 Common Stock done at an average price of $174.1 . Disclosure was reported to the exchange on March 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 174.13 per share. | 05 Mar 2025 | 5,370 | 68,068 (0%) | 0% | 174.1 | 935,078 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 173.74 per share. | 03 Mar 2025 | 10,380 | 78,448 (0%) | 0% | 173.7 | 1,803,421 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 5,010 | 73,438 (0%) | 0% | 173.7 | 870,437 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 175.79 per share. | 03 Mar 2025 | 716 | 68,068 (0%) | 0% | 175.8 | 125,866 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 394 | 68,784 (0%) | 0% | 173.7 | 68,454 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 172.61 per share. | 26 Feb 2025 | 824 | 69,178 (0%) | 0% | 172.6 | 142,231 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 171.75 per share. | 26 Feb 2025 | 455 | 70,002 (0%) | 0% | 171.7 | 78,146 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 170.99 per share. | 19 Feb 2025 | 899 | 70,457 (0%) | 0% | 171.0 | 153,720 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 169.71 per share. | 19 Feb 2025 | 535 | 71,356 (0%) | 0% | 169.7 | 90,795 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,344 | 13,344 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 3,479 | 71,891 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 33,103 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.57 per share. | 27 Nov 2024 | 33,103 | 101,515 (0%) | 0% | 103.6 | 3,428,478 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 163.13 per share. | 27 Nov 2024 | 28,300 | 68,412 (0%) | 0% | 163.1 | 4,616,709 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 162.14 per share. | 27 Nov 2024 | 4,803 | 96,712 (0%) | 0% | 162.1 | 778,775 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 126.57 per share. | 28 Feb 2024 | 5,557 | 69,599 (0%) | 0% | 126.6 | 703,349 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 125.88 per share. | 28 Feb 2024 | 1,187 | 68,412 (0%) | 0% | 125.9 | 149,420 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 644 | 75,713 (0%) | 0% | 126.4 | 81,376 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 557 | 75,156 (0%) | 0% | 126.4 | 70,383 | Common Stock |
| Quest Diagnostics | T. Catherine Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 125.02 per share. | 23 Feb 2024 | 9,314 | 80,114 (0%) | 0% | 125.0 | 1,164,436 | Common Stock |
| Quest Diagnostics | Doherty Catherine T. | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 23 Feb 2024 | 3,757 | 76,357 (0%) | 0% | 125.0 | 469,700 | Common Stock |
| Quest Diagnostics | T. Catherine Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 126.14 per share. | 21 Feb 2024 | 821 | 70,800 (0%) | 0% | 126.1 | 103,561 | Common Stock |
| Quest Diagnostics | T. Catherine Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 21 Feb 2024 | 493 | 71,621 (0%) | 0% | 125.0 | 61,635 | Common Stock |
| Quest Diagnostics | Doherty T. Catherine | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 17,939 | 17,939 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | T. Doherty Catherine | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 4,304 | 72,114 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 147.86 per share. | 06 Mar 2023 | 9,917 | 77,727 (0%) | 0% | 147.9 | 1,466,328 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 140.55 per share. | 06 Mar 2023 | 5,307 | 67,810 (0%) | 0% | 140.6 | 745,899 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 06 Mar 2023 | 4,610 | 73,117 (0%) | 0% | 147.9 | 681,635 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 140.63 per share. | 03 Mar 2023 | 717 | 67,810 (0%) | 0% | 140.6 | 100,832 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.69 per share. | 01 Mar 2023 | 392 | 68,527 (0%) | 0% | 140.7 | 55,150 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 15,167 | 15,167 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,838 | 70,609 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 141.42 per share. | 23 Feb 2023 | 1,690 | 68,919 (0%) | 0% | 141.4 | 239,000 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 23 Feb 2023 | 962 | 66,771 (0%) | 0% | 147.9 | 142,241 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 40,765 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.63 per share. | 28 Nov 2022 | 40,765 | 108,498 (0%) | 0% | 86.6 | 3,531,472 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 149.37 per share. | 28 Nov 2022 | 23,407 | 67,733 (0%) | 0% | 149.4 | 3,496,390 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 148.92 per share. | 28 Nov 2022 | 17,358 | 91,140 (0%) | 0% | 148.9 | 2,584,872 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 130.09 per share. | 07 Mar 2022 | 13,392 | 81,125 (0%) | 0% | 130.1 | 1,742,165 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 135.21 per share. | 07 Mar 2022 | 7,032 | 67,733 (0%) | 0% | 135.2 | 950,797 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 07 Mar 2022 | 6,360 | 74,765 (0%) | 0% | 130.1 | 827,372 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 16,155 | 16,155 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 3,328 | 67,733 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 126.26 per share. | 24 Feb 2022 | 2,750 | 64,405 (0%) | 0% | 126.3 | 347,215 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 23 Feb 2022 | 1,082 | 67,647 (0%) | 0% | 130.1 | 140,757 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.23 per share. | 23 Feb 2022 | 492 | 67,155 (0%) | 0% | 130.2 | 64,073 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.79 per share. | 29 Nov 2021 | 37,565 | 106,294 (0%) | 0% | 95.8 | 3,598,539 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2021 | 37,565 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 156.85 per share. | 29 Nov 2021 | 15,908 | 83,304 (0%) | 0% | 156.9 | 2,495,249 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 157.53 per share. | 29 Nov 2021 | 14,575 | 68,729 (0%) | 0% | 157.5 | 2,296,043 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 155.77 per share. | 29 Nov 2021 | 3,532 | 99,212 (0%) | 0% | 155.8 | 550,194 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 154.79 per share. | 29 Nov 2021 | 3,250 | 102,744 (0%) | 0% | 154.8 | 503,074 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 153.38 per share. | 29 Nov 2021 | 300 | 105,994 (0%) | 0% | 153.4 | 46,015 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 139.96 per share. | 07 May 2021 | 8,536 | 68,729 (0%) | 0% | 140.0 | 1,194,724 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 115.42 per share. | 09 Mar 2021 | 11,299 | 82,331 (0%) | 0% | 115.4 | 1,304,131 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.42 per share. | 09 Mar 2021 | 5,066 | 77,265 (0%) | 0% | 115.4 | 584,718 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.15 per share. | 23 Feb 2021 | 796 | 71,556 (0%) | 0% | 121.1 | 96,435 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.19 per share. | 23 Feb 2021 | 524 | 71,032 (0%) | 0% | 121.2 | 63,504 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 22,105 | 22,105 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,941 | 72,352 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.51 per share. | 02 Sep 2020 | 58,392 | 126,803 (0%) | 0% | 66.5 | 3,883,652 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2020 | 58,392 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 110.57 per share. | 02 Sep 2020 | 54,616 | 72,187 (0%) | 0% | 110.6 | 6,038,727 | Common Stock |
| Quest Diagnostics | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 111.13 per share. | 02 Sep 2020 | 3,776 | 68,411 (0%) | 0% | 111.1 | 419,616 | Common Stock |